Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - RESEARCH & DEVELOPMENT
Research & Development NVAX - Novavax, Inc.
738 M
LAST VALUE
-46.06%
2 YEAR CAGR
33.52%
5 YEAR CAGR
30.80%
10 YEAR CAGR